Search clinical trials for: Lipoxin A4

Total 406 results

Tianjin Medical University Cancer Institute and...

Unknown

Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors

Malignant Solid Tumors

China
Peking University
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
White, Katharine O'Connell, M.D., M.P.H.
Society of Family Planning

Completed

A Trial of Digoxin Before Second-Trimester Abortion

Induced Abortion

United States
University Hospital, Basel, Switzerland
ETH Zurich - The Aceto Lab

Completed

Digoxin Induced Dissolution of CTC Clusters

Breast Cancer | Circulating Tumor Cells (CTCs)

Switzerland
University of Illinois at Chicago
American College of Clinical Pharmacy

Completed

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care

Heart Failure

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.

Healthy
Y Biologics Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Korea, Republic of, Thailand, Australia
Yale University

Recruiting

Digoxin In Treatment of Alcohol Associated Hepatitis (DIGIT-AlcHep)

Alcohol-Induced Disorders | Chemical and Drug Induced Liver Injury | Acute Alcoholic Hepatitis | Steatohepatitis Caused by Ingestible Alcohol

United States
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd

Completed

Drug Interaction Study of Isavuconazole and Digoxin

Healthy Volunteers | Pharmacokinetics of Isavuconazole | Pharmacokinetics of Digoxin

United States
University of Texas Southwestern Medical Center

Withdrawn

A Clinical Trial of Patients With Melanoma

Melanoma

United States
Janssen Research & Development, LLC
Bristol-Myers Squibb

Completed

A Study of JNJ-70033093 and Digoxin in Healthy Participants

Healthy

Belgium
Gaia AG
University Hospital, Aachen; Deutsche Stiftung für chronisch Kranke

Not yet recruiting

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels (DIGICHOL)

Dyslipidemias | Hypercholesterolemia

Germany
Makerere University
Karolinska Institutet; Swedish International Development Cooperation Agency...

Unknown

Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics and Population Pharmacokinetics

Malaria, Falciparum

Uganda
First Affiliated Hospital Xi'an Jiaotong University

Completed

The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects

Healthy

China
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer

Head and Neck Cancer

United States
Western Regional Medical Center

Terminated

Capecitabine With Digoxin for Metastatic Breast Cancer

Metastatic Breast Cancer

United States
University of California, Los Angeles

Completed

Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion

Abortion, Induced
AstraZeneca
Bristol-Myers Squibb

Completed

Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
Mateon Therapeutics

Completed

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers (GI-NETorPNET)

Neuroendocrine Tumors

United States
Lipotek Pty Ltd
Royal Adelaide Hospital; Trident Clinical Research Pty Ltd

Completed

Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma

Melanoma

Australia
Cairo University

Completed

A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital

Atrial Fibrillation
Hospital Ana Nery

Unknown

Intensive Versus Conventional Digoxin Use in Patients With Heart Failure (ICHF)

Heart Failure

Brazil
Mateon Therapeutics

Terminated

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Platinum Resistant Ovarian Cancer

United States, Belgium, Germany
Genzyme, a Sanofi Company

Completed

A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults

Healthy Volunteer

United States
GlaxoSmithKline

Completed

An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed

Epilepsy

United States
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178

Healthy

France
Assistance Publique - Hôpitaux de Paris

Unknown

Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma (KADIG 01)

Kaposi' s Sarcoma | Classic Kaposi' s Sarcoma | Endemic Kaposi' s Sarcoma | Lymph Angio Proliferations

France
Pfizer
Medivation, Inc.

Completed

Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects

Alzheimer Disease | Huntington Disease

United States
University of Monastir

Completed

Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients

Atrial Fibrillation

Tunisia
Hoffmann-La Roche

Completed

A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers

Healthy Volunteer

United Kingdom
Cocco, Giuseppe, M.D.
Cardiology Office, Rheinfelden, Switzerland

Completed

Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function (DIGvsIVA)

Heart Failure | Atrial Fibrillation

Switzerland
AnHeart Therapeutics Inc.

Completed

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Solid Tumor

China
University of Leeds

Not yet recruiting

Digoxin and Senolysis in Heart Failure and Diabetes Mellitus

Diabetes Mellitus, Type 2 | Heart Failure, Systolic

United Kingdom
The Alfred

Completed

Digoxin Withdrawal in Stable Heart Failure

Heart Failure

Australia
Mie University
Fiverings Co., Ltd.; Shionogi; Takara Bio Inc.; Statcom Co. Ltd.

Completed

Investigator Initiated Phase 1 Study of TBI-1201

Solid Tumors

Japan
National Institute on Aging (NIA)
University of Toledo Health Science Campus

Unknown

Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease

Hypertension | Hemodialysis

United States
Meir Medical Center

Unknown

Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy

Arrhythmia | Hypotension | ECG Changes

Israel
Boehringer Ingelheim

Completed

to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers

Healthy

Germany
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers

Essential Hypertension
Bial - Portela C S.A.

Completed

The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin

Epilepsy

Portugal
Rebecca Spain

Completed

Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

Progressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United States
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Yale University

Withdrawn

Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis

China
AMAG Pharmaceuticals, Inc.

Terminated

Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia

Severe Preeclampsia

United States, Poland, South Africa
Chun-Yao Huang

Unknown

Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction

Heart Failure | Atrial Fibrillation | Ivabradine

Taiwan
InVasc Therapeutics, Inc.

Completed

Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension (QUALITY)

Hypertension | Diabetes

United States
Radboud University Medical Center

Completed

Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma (DIGUP-TC)

Non-Medullary Thyroid Carcinoma

Netherlands
Frederiksberg University Hospital
Oak Foundation; Axellus

Completed

Rosehip Powder for Knee Osteoarthritis

Osteoarthritis

Denmark
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)

Healthy Volunteers Study

Canada
Oregon Health and Science University
National Center for Complementary and Integrative Health (NCCIH)

Completed

A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis

Multiple Sclerosis

United States
Mateon Therapeutics

Completed

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Tumors

United Kingdom

Search clinical trials for: Lipoxin A4

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations